Curcumin enhances the anti-cancer efficacy of paclitaxel in ovarian cancer by regulating the miR-9-5p/BRCA1 axis

Background: Patients with late-stage ovarian cancer still have a very poor prognosis due to chemotherapy resistance. Curcumin has been shown to synergistically enhance the therapeutic effects of multiple chemotherapeutic agents, but the potential involvement of curcumin in ovarian cancer is largely...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Yuwan, Shen, Zhangjin, Zhu, Tingjia, Lu, Weiguo, Fu, Yunfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871306/
https://www.ncbi.nlm.nih.gov/pubmed/36703740
http://dx.doi.org/10.3389/fphar.2022.1014933

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9871306/
https://www.ncbi.nlm.nih.gov/pubmed/36703740
http://dx.doi.org/10.3389/fphar.2022.1014933

Ejemplares similares